KALA Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect 眼科查看全文
發仔说美股2022-12-30 17:30
【美股盘前 | 药品制造商Kala续涨超6%,Wedbush予其47美元目标价】
华盛资讯12月30日消息,美股盘前,三大期指走弱,截至发稿,纳指期货跌0.61%,标普500指数期货跌0.45%,道指期货跌0.32%。
药物制造商Kala Pharmaceuticals盘前上涨6.68%,近两个交易日涨逾317%,Wedbush分析师Andreas Ar...查看全文
一周一次的见面会又来了,还是我→美股风向标。致力于追踪热门美股优质标的,挖掘更多投资机会。接下来我们来看看本周有哪些重要的标的可以关注吧! 1、Kala制药公司 $KALA 表示,FDA接受了其主要候选产品KPI-012——治疗眼睛罕见疾病的研究... 网页链接
智通财经APP获悉,专注于眼部护理的全球医疗专业公司爱尔康(ALC.US)宣布,同意从生物制药公司Kala Pharma(KALA.US)手中收购EYSUVIS(0.25%氯替泼诺混悬滴眼液)和INVELTYS(1%氯替泼诺混悬滴眼液)。 据了解,EYSUVIS是首个也是唯一一个获FD... 网页链接
$Kala制药(KALA)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001558370-19-000060 Size: 26 KBItem 7.01: Regulation FD Disclosure 网页链接
$Kala制药(KALA)$ 8-K - Current report Filed: 2018-12-20 AccNo: 0001558370-18-009767 Size: 23 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-12-20 AccNo: 0001558370-18-009767 Size: 23 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:/...
$Kala Pharmaceuticals, Inc.(KALA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-08 AccNo: 0001558370-18-009054 Size: 6 MB 网页链接
$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001558370-18-009002 Size: 189 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-11-01 AccNo: 0001558370-18-008253 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:/...
$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-10-16 AccNo: 0001104659-18-062242 Size: 20 KBItem 8.01: Other Events 网页链接
$Kala Pharmaceuticals, Inc.(KALA)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-10-12 AccNo: 0001144204-18-053658 Size: 159 KB 网页链接
$Kala Pharmaceuticals, Inc.(KALA)$ 8-K - Current report Filed: 2018-10-11 AccNo: 0001558370-18-007676 Size: 40 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Kala Pharmaceuticals, Inc.(KALA)$ CT ORDER - Confidential treatment order Filed: 2018-10-09 AccNo: 9999999997-18-008524 Size: 11 KB 网页链接